Manipulating immune checkpoint signalling pathways with antibodies
<p>Immune checkpoint receptors are critical regulators of immune tolerance. Antibodies blocking these pathways can enhance immune responses and in recent years have revolutionised the treatment of cancer. The converse approach of developing agonistic antibodies against checkpoint receptors to...
| Main Author: | |
|---|---|
| Other Authors: | |
| Format: | Thesis |
| Language: | English |
| Published: |
2019
|